CompletedNot Applicable

Glioma and Exercising

Switzerland39 participantsStarted 2018-10-26

Plain-language summary

To investigate the influence of two physical activity and exercising (PAE) interventions, namely resistance training and endurance training in relation to quality of life, depression, fatigue, sleep, anxiety, stress and coping, body image, and social interactions (psychological dimensions); cardiorespiratory fitness, morning cortisol secretion, inflammatory markers, and objective sleep (physiological dimensions), along with cancer-related dimensions

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with high grade glioma (WHO III° and IV°), and undergoing radiotherapy, chemotherapy, or both * Willing and able to follow the study intervention * Signed written informed consent Exclusion Criteria: * Severe psychiatric (psychosis, suicidal behavior, substance use disorder) and somatic comorbidities (severe cardiovascular disease, severe diabetes, impairments of the musculo-skeletal system) * patients not willing or able anymore to follow the study protocol.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Functional Assessment of Cancer Therapy Scale (FACT)

Timeframe: Baseline and week 3 and week 6

Change in Hamilton Depression Rating Scale (HDRS)

Timeframe: Baseline and week 3 and week 6

Change in Intolerance of Uncertainty Scale (IU)

Timeframe: Baseline and week 3 and week 6

Change in Insomnia Severity Index (ISI)

Timeframe: Baseline and week 3 and week 6

Change in Perceived Stress Scale (PSS)

Timeframe: Baseline and week 3 and week 6

Change in Fatigue Severity Scale

Timeframe: Baseline and week 3 and week 6

Change in Mental Toughness Questionnaire (MTQ48)

Timeframe: Baseline and week 3 and week 6

Trial details

NCT IDNCT03775369

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More High Grade Glioma trials

Plain-language summary

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Functional Assessment of Cancer Therapy Scale (FACT)

Timeframe: Baseline and week 3 and week 6

Change in Hamilton Depression Rating Scale (HDRS)

Timeframe: Baseline and week 3 and week 6

Change in Intolerance of Uncertainty Scale (IU)

Timeframe: Baseline and week 3 and week 6

Change in Insomnia Severity Index (ISI)

Timeframe: Baseline and week 3 and week 6

Change in Perceived Stress Scale (PSS)

Timeframe: Baseline and week 3 and week 6

Change in Fatigue Severity Scale

Timeframe: Baseline and week 3 and week 6

Change in Mental Toughness Questionnaire (MTQ48)

Timeframe: Baseline and week 3 and week 6